6 Recommendations for research
6.1 The committee was aware that an ongoing randomised controlled trial exploring the occurrence of cardiovascular events of alirocumab compared with placebo are available is expected in 2018. The committee agreed that this trial would give useful data on the direct effect of alirocumab on cardiovascular disease.